Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: John Metcalf who wrote (2281)	4/11/1999 12:55:00 AM
From: quidditch	Respond to of 10280

Somewhat OT, it is rather ironic that SEPR's backing and filling, or whatever Mazen would call it in a more technical vein, started right after Southwell's call that he agreed with the assumptions underlying MS analyst's call for $12.00 (or whatever the number) EPS in 2003. Some professionals thought that this was a bit reckless for a Company insider looking out that timeframe. Am long SEPR and hope Southwell is right, but I suspect that what will keep the lid on this stock, relatively speaking, will be the ever-increasing estimates for R&D, product roll-out expenses and marketing and sales force. Regards. Liacos_samui